middle.news

PolyNovo Surges with 29% Sales Growth and A$33.5m Cash Boost in FY25

7:06pm on Tuesday 29th of July, 2025 AEST Healthcare
Read Story

PolyNovo Surges with 29% Sales Growth and A$33.5m Cash Boost in FY25

7:06pm on Tuesday 29th of July, 2025 AEST
Key Points
  • FY25 sales up 28.9% to A$118.6 million
  • Cash and equivalents rose to A$33.5 million by June 2025
  • EBITDA expected between A$11.2 million and A$12.4 million, up from A$3.6 million last year
  • Strong U.S. sales growth with 89 field staff and 58% increase in sales orders
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about PNV
OPEN ARTICLE